UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000037403
Receipt number R000042647
Scientific Title Retrospective analysis of the prospective cohort of patients with chronic heart failure on atrial fibrillation, cancer and anti-thrombolytic therapy: The CHART-2_Cancer_AF Study
Date of disclosure of the study information 2019/07/17
Last modified on 2023/11/13 11:53:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Retrospective analysis of the prospective cohort of patients with chronic heart failure on atrial fibrillation, cancer and anti-thrombolytic therapy: The CHART-2_Cancer_AF Study

Acronym

The CHART-2_Cancer_AF Study

Scientific Title

Retrospective analysis of the prospective cohort of patients with chronic heart failure on atrial fibrillation, cancer and anti-thrombolytic therapy: The CHART-2_Cancer_AF Study

Scientific Title:Acronym

The CHART-2_Cancer_AF Study

Region

Japan


Condition

Condition

Patients with chronic heart failure

Classification by specialty

Medicine in general Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine incidence of cancer and other clinical outcomes in patients with chronic heart failure and atrial fibrillation with a reference to anti-thrombolytic therapy

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

A composite of stroke, systemic thromboembolism and ISTH major bleeding events

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Structural heart disease but without signs or symptoms of heart failure.
2) Structural heart disease with prior or current symptoms of heart failure.
3) Refractory heart failure requiring specialized interventions.
4) Patients with prior cardiovascular surgery or percutaneous coronary intervention and those who need such interventions.

Key exclusion criteria

None

Target sample size

10219


Research contact person

Name of lead principal investigator

1st name Yasuhiko
Middle name
Last name Sakata

Organization

Tohoku University Graduate School of Medicine

Division name

Department of Cardiovascular Medicine

Zip code

980-8574

Address

1-1, Seiryo-machi, Aoba-ku, Sendai, Japan

TEL

022-717-7153

Email

sakatayk@cardio.med.tohoku.ac.jp


Public contact

Name of contact person

1st name Kotaro
Middle name
Last name Nochioka

Organization

Tohoku University Graduate School of Medicine

Division name

Department of Cardiovascular Medicine

Zip code

980-8574

Address

1-1, Seiryo-machi, Aoba-ku, Sendai, Japan

TEL

022-717-7153

Homepage URL


Email

nochioka@cardio.med.tohoku.ac.jp


Sponsor or person

Institute

Tohoku University

Institute

Department

Personal name



Funding Source

Organization

Daiichi-Sankyo

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics Committee of Tohoku University Graduate School of Medicine

Address

1-1, Seiryo-machi, Aoba-ku, Sendai, 9808574 Japan

Tel

+81-22-717-8007

Email

med-kenkyo@grp.tohoku.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2019 Year 07 Month 17 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

10219

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2019 Year 03 Month 31 Day

Date of IRB

2018 Year 05 Month 16 Day

Anticipated trial start date

2019 Year 04 Month 01 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Observational study


Management information

Registered date

2019 Year 07 Month 17 Day

Last modified on

2023 Year 11 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042647


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name